Assessing the Significance of BRCA1 and BRCA2 Mutations in Pancreatic Cancer

被引：25
|
作者：
Carnevale, Julia [1 ]
Ashworth, Alan [1 ]
机构：
[1] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 28期
关键词：
PALB2;
D O I：
10.1200/JCO.2015.61.6961
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3080 / +
页数：3
相关论文
共 50 条
  • [41] Are Endometrial Cancers Arising in BRCA1/BRCA2 Germline Mutations Carriers True BRCA1/BRCA2 Cancers?
    Paula, Arnaud Da Cruz
    Smith, Evan
    Cadoo, Karen
    Abu-Rustum, Nadeem
    Pei, Xin
    Riaz, Nadeem
    Robson, Mark
    Reis-Filho, Jorge
    Mandelker, Diana
    Weigelt, Britta
    MODERN PATHOLOGY, 2019, 32
  • [42] Are Endometrial Cancers Arising in BRCA1/BRCA2 Germline Mutations Carriers True BRCA1/BRCA2 Cancers?
    Paula, Arnaud Da Cruz
    Smith, Evan
    Cadoo, Karen
    Abu-Rustum, Nadeem
    Pei, Xin
    Riaz, Nadeem
    Robson, Mark
    Reis-Filho, Jorge
    Mandelker, Diana
    Weigelt, Britta
    LABORATORY INVESTIGATION, 2019, 99
  • [43] Pedigree analysis equally identifies cases of pancreatic cancer in families with BRCA1 and BRCA2 mutations
    Schrock, Evelin
    Hackmann, Karl
    Kuhlee, Franziska
    Jahn, Arne
    Wagner, Johannes
    Kahlert, Anne-Karin
    Porrmann, Joseph
    Tzschach, Andreas
    Aust, Daniela
    Baretton, Gustavo
    Kast, Karin
    Wimberger, Pauline
    Laniado, Michael
    Kahlert, Christoph
    Welsch, Thilo
    Weitz, Juergen
    Klink, Barbara
    Rump, Andreas
    Gieldon, Laura
    CANCER RESEARCH, 2018, 78 (13)
  • [44] BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts
    Lohse, I.
    Borgida, A.
    Cao, P.
    Cheung, M.
    Pintilie, M.
    Bianco, T.
    Holter, S.
    Ibrahimov, E.
    Kumareswaran, R.
    Bristow, R. G.
    Tsao, M-S
    Gallinger, S.
    Hedley, D. W.
    BRITISH JOURNAL OF CANCER, 2015, 113 (03) : 425 - 432
  • [45] BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts
    I Lohse
    A Borgida
    P Cao
    M Cheung
    M Pintilie
    T Bianco
    S Holter
    E Ibrahimov
    R Kumareswaran
    R G Bristow
    M-S Tsao
    S Gallinger
    D W Hedley
    British Journal of Cancer, 2015, 113 : 425 - 432
  • [46] BRCA1 and BRCA2
    Bertwistle, D
    Ashworth, A
    CURRENT BIOLOGY, 2000, 10 (16) : R582 - R582
  • [47] Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer
    Evans, D. G.
    Howell, A.
    Ward, D.
    Lalloo, F.
    Jones, J. L.
    Eccles, D. M.
    JOURNAL OF MEDICAL GENETICS, 2011, 48 (08) : 520 - 522
  • [48] High incidence of mutations in BRCA1 and BRCA2 genes in ovarian cancer
    Smirnova, T. Yu.
    Pospekhova, N. I.
    Lyubchenko, L. N.
    Tjulandin, S. A.
    Gar'kavtseva, R. F.
    Ginter, E. K.
    Karpukhin, A. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 144 (01) : 83 - 85
  • [49] Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer
    Steinmann, D
    Bremer, M
    Rades, D
    Skawran, B
    Siebrands, C
    Karstens, JH
    Dörk, T
    BRITISH JOURNAL OF CANCER, 2001, 85 (06) : 850 - 858
  • [50] BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer - Response
    Rennert, G
    Bonner, JD
    Gruber, SB
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (15): : 1185 - 1186
12345